The Experiment Cost Inflection Point

Understanding how a data platform can make experiments less expensive or more reliable (but rarely both).

Many people have written about the benefits of running quick, inexpensive experiments.

But one of the earliest lessons I learned in biotech is that for some experiments, it’s actually better to make them slower and more expensive…

… if that means making them more reliable.

In this month’s blog post, The Experiment Cost Inflection Point, I explore why we tend to push inexpensive experiments towards being cheaper, but push expensive experiments towards being more expensive, as well as how the design decisions within a data platform impact these dynamics.